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ABSTRACT
Mutations in key transcription factors SOX2 and P63 were linked with developmental defects
and postnatal abnormalities such as corneal opaciﬁcation, neovascularization, and blindness. The
latter phenotypes suggest that SOX2 and P63 may be involved in corneal epithelial regeneration.
Although P63 has been shown to be a key regulator of limbal stem cells, the expression pattern
and function of SOX2 in the adult cornea remained unclear. Here, we show that SOX2 regulates
P63 to control corneal epithelial stem/progenitor cell function. SOX2 and P63 were co-expressed
in the stem/progenitor cell compartments of the murine cornea in vivo and in undifferentiated
human limbal epithelial stem/progenitor cells in vitro. In line, a new consensus site that allows
SOX2-mediated regulation of P63 enhancer was identiﬁed while repression of SOX2 reduced P63
expression, suggesting that SOX2 is upstream to P63. Importantly, knockdown of SOX2 signiﬁ-
cantly attenuated cell proliferation, long-term colony-forming potential of stem/progenitor cells,
and induced robust cell differentiation. However, this effect was reverted by forced expression of
P63, suggesting that SOX2 acts, at least in part, through P63. Finally, miR-450b was identiﬁed as a
direct repressor of SOX2 that was required for SOX2/P63 downregulation and cell differentiation.
Altogether, we propose that SOX2/P63 pathway is an essential regulator of corneal stem/progeni-
tor cells while mutations in SOX2 or P63 may disrupt epithelial regeneration, leading to loss of
corneal transparency and blindness. STEM CELLS 2019;37:417–429
SIGNIFICANCE STATEMENT
The role of transcription factors in the regulation of limbal epithelial stem cell self-renewal and
differentiation is poorly understood. This study demonstrates that SOX2 regulates and interacts
with P63 and that both transcription factors control the stem/progenitor cell state. By contrast,
downregulation of SOX2/P63 by miR-450b induces cell differentiation. Given that congenital
point mutations in SOX2 or P63 were linked with multiple eye abnormities, a better understand-
ing of this molecular network will shed light on disease mechanisms and may potentially be
harnessed into novel therapeutic approaches to restore vision.
INTRODUCTION
The corneal epithelium is the outermost trans-
parent tissue that serves as a barrier against
external insults and undergoes continuous
regeneration by stem cells. The unique com-
partmentalization of stem, progenitor, and dif-
ferentiated cells to spatially segregated regions
makes the cornea an excellent model for stem
cell biology. The stem cells of the cornea reside
in a ring-shaped zone in the corneal periphery,
known as the limbus. Slow cycling cells were
identiﬁed in the limbal epithelium [1] and
indeed, lineage tracing experiments conﬁrmed
that the limbus is the main if not only source
of long-term corneal regeneration [2, 3]. Limbal
stem cells (LSCs) which were recently labeled
by K15-GFP reporter transgene [4] give rise to
progenitor cells that undergo centripetal move-
ment toward the corneal center, and upon
their transition to the supra basal layers of the
corneal epithelium, they become post-mitotic,
terminally differentiated, and shed off the eye.
Uncontrolled LSC activity may lead to abnormal
balance between proliferation and differentia-
tion and give rise to tissue hyperplasia and
cancer. Conversely, in case of irreversible loss
or damage to LSCs, the cornea becomes neo-
vascularized, its transparency is lost, leading to
visual impairment and blindness [5–8]. LSC
deﬁciency (LSCD) can be caused by various
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factors including eye burn, inﬂammation, and hereditary dis-
ease. Point mutations in PAX6 [9–11] and P63 [12, 13] lead to
multiple eye abnormalities including LSCD. In line, P63 regu-
lates corneal development [13] and epithelial stem cell mainte-
nance [14, 15] while P63 expression was positively correlated
with successful outcome of LSC therapy [16]. Mutations in
SOX2 were linked with anophthalmia (eye absence) in some
patients [17–20], consistent with the critical role of SOX2 in
early eye development [21, 22]. However, the expression and
role of SOX2 in the adult stage cornea remained virtually
unknown.
In the present study, we provide evidence that SOX2 is
essential for corneal epithelial stem/progenitor cell state. SOX2
was co-expressed with and controlled P63, and in line, SOX2
prevented cell differentiation and was essential for colony-
forming capacity and cell proliferation. Finally, miR-450b was
identiﬁed as a direct repressor of SOX2 which was essential for
the downregulation of SOX2/P63 pathway and the induction
of cell differentiation.
MATERIALS AND METHODS
Cell Culture, Differentiation, Transfection, and Cloning
Cells were cultured at 37C, 5% CO2, and 20% O2. Human lim-
bal rings from cadaveric corneas were obtained post-mortem
under the approval of the local ethical committee. Epithelium
was separated from the underlying stroma following incuba-
tion with dispase (Gibco, Life Technologies, USA). Cells were
grown in co-culture with mitomycinized growth-arrested
J2-NIH3T3 cells (40 × 103 cells per square centimeter) in epi-
thelial medium, as previously described [23]. For efﬁcient
transfection and for controlled calcium-induced differentiation,
cells were switched to deﬁned medium with supplements
(SCMK001, Millipore, USA) containing 1% penicillin/streptomy-
cin and low calcium (150 μM). For differentiation, 15 x 104
cells per square centimeter were seeded, grown to 80%–100%
conﬂuence, and then switched to high (1.2 mM) calcium for
up to 1 week.
Cells were collected at indicated time points for different
analyses. Clonogenicity test [23, 24], corneal epithelial differen-
tiation of human embryonic stem cells [25–27], and neural
differentiation of mouse embryonic stem cells [28] were car-
ried out as previously reported. For cell proliferation assay,
cells were transfected with indicated factors, and 48 hours
later, cell proliferation was measured with alamar blue
(Biorad) as detailed in the kit. For cell viability assay after
transfection, trypan blue assay was performed (Sigma, UK,
93595). HEK293 cells were grown in high glucose- and L-gluta-
mine-containing Dulbecco’s modiﬁed Eagle’s medium (Lonza,
Verviers, Belgium) supplemented with 10% fetal bovine serum
(Invitrogen, Darmstadt, Germany). For transfections, cells were
seeded on Collagen I (Sigma, USA, C8919)-coated dishes and
on the next day co-transfected (Lipofectamine 3000 Invitrogen)
with 40 ng of Renilla luciferase vector (pRL-CMV), pMIR-
REPORT SOX2-30 untranslated region (UTR) vector (400 ng,
kind gift of K. S. Kosik [29]), and pre-miR mimic or control oli-
gonucleotides (50 nM). Alternatively, cells were transfected
with indicated transcription factor encoding plasmids (1 μg),
P63 enhancer luciferase constructs (500 ng, kind gift of
C. Missero), or speciﬁc endonuclease-digested silencing RNAs
(esiRNAs; 50 nM). Luciferase activity was measured 48 hours
after transfection using Dual-Luciferase Reporter Assay System
(Promega, USA), and light emission was measured over 10 sec-
onds. The efﬁciency of transfection was normalized to Renilla.
Cloning of the MUT-SOX2-30UTR was done by ligation of a
double stranded DNA fragment containing the entire length of
SOX2-30UTR that contains point mutations in all ﬁve predicted
binding sites (for the sequence, see Supporting Information Fig. S4).
For C38-C40-MUT-SOX2 plasmid, SOX2 binding site (atgaatgttcttgt)
was mutated (to acacggtttcaagt) by polymerase chain reaction
(PCR) using Fwd-50gcctagtacttgaaaccgtgtctcccaaacacatcatttc30 and
Rev-50aagacatagcttgcaggagaacatctggagc30 primers.
All esiRNA reagents were from Sigma, USA including esiRNA-
SOX2 (EHU184131), esiRNA-P63 (EHU122601), and control
esiRNA against Enhanced Green Fluorescent Protein (EHUEGFP),
Renilla Luciferase (EHURLUC), and SIC004. PM450a (AM17100)
and PM450b (AM17100) mimic or AM450a (AM17000) and
AM450b (AM17000) inhibitor and their control oligos (Ctl-PM–
AM17120) and Ctl-AM (AM17012) were from Ambion, USA.
Western Blots, Immunoprecipitation, Immunostaining,
and Flow Cytometry
Cells were washed with cold phosphate-buffered saline (PBS)
twice, and lysates were obtained in RIPA buffer (Tris-HCl
10 mM, 10 mg/ml deoxycholate, 1% NP40, 1% SDS, 150 mM
NaCl, and protease inhibitors cocktail [Roche, Mannheim,
Germany]). Total protein was subjected to polyacrylamide gel
electrophoresis in the presence of sodium dodecyl sulfate. Pro-
teins were separated on 12% polyacrylamide gel and trans-
ferred to nitrocellulose membranes (Bio-Rad) as reported
[30–32]. The membranes were blocked with trisma base buffer
supplemented with 0.1% tween 20 (TBST, Sigma, USA) contain-
ing 5% milk (Bio-Rad, USA) and probed with one of the follow-
ing antibodies diluted in blocking solution: rabbit anti-SOX2
(1:1,000, Millipore, USA), mouse anti-P63 (1:500, 4A4 Santa
Cruz Biotechnology, USA), mouse anti-K14 (1:1,000, Millipore,
USA), mouse anti-K3 (1:1,000, Millipore, USA), goat anti-K12
(1:1,000, Santa Cruz Biotechnology, USA), and rabbit anti-ERK
(1:3,500, Santa Cruz Biotechnology, USA) at 4C, overnight, fol-
lowed by three washes with TBST. Furthermore, the membranes
were exposed to peroxidase-conjugated goat anti-mouse IgG or
peroxidase-conjugated goat anti-rabbit IgG or peroxidase-
conjugated donkey anti-goat IgG (all at 1:3,000) for 1 hour at
room temperature and washed three times with TBST. Protein
bands were visualized with EZ-ECL Enhanced Chemilumine-
scence Detection Kit (Biological Industries, Israel). Immunopre-
cipitation was performed as previously described [33] with 5 μg
of rabbit anti-SOX2 and 5 μg of rabbit anti-myc.
For immunoﬂuorescent staining, cells that were grown on
glass coverslips were washed with PBS, ﬁxed for 15 minutes in
4% paraformaldehyde (Sigma, USA) in PBS, and then permea-
bilized with 0.1% Triton X-100 (BioLab, Israel) in PBS for
10 minutes. Blocking was performed in saturation buffer (PBS
with 3% bovine serum albumin [Biological Industries, USA], 3%
donkey serum [Jackson, USA], and 0.1% Triton X-100) for at
least 1 hour at room temperature in order to prevent unspeci-
ﬁc antibody binding. Following these treatments, cells were
incubated for 1 hour at room temperature with primary antibody
mouse anti-SOX2 (1:100; Millipore, USA), rabbit anti-SOX2 (1:100;
Abcam, UK), mouse anti-P63 (1:100; Santa Cruz Biotechnology, USA),
©2018 The Authors. STEM CELLS published by
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rabbit anti-K14 (1:400; Covance, USA), rabbit anti-K12 (1:400;
Abcam, UK), rabbit anti-K3 (1:400; Millipore, USA), rabbit anti-
Ki67 (1:100; Santa Cruz Biotechnology, USA), mouse anti-TUJ1
(1:100; Covance, USA), and mouse anti-NESTIN (1:100; BD
Pharmingen, USA) diluted in saturation buffer and washed
three times with PBS. Next, cells were incubated for 1 hour at
room temperature with secondary antibody (1:500) in satura-
tion buffer, washed three times with PBS, and nuclei were
stained with 40,6-diamidino-2-phenylindole dihydrochloride
(Sigma, USA) and mounted (Thermo Scientiﬁc, USA). Secondary
antibodies were Alexa Fluor-488 donkey anti-mouse IgG or
Alexa Fluor-594 donkey anti-mouse IgG or Alexa Fluor-488 don-
key anti-rabbit IgG or Alexa Fluor-594 donkey anti-rabbit IgG,
diluted 1:500. Images were taken by Nikon Eclipse NI-E upright
microscope, and quantiﬁcation was performed using Nis-
elements Analysis D software. Five to ten different ﬁelds were
imaged and the average ﬂuorescence intensity was calculated.
Quantitative Real-Time Polymerase Chain Reaction and
TaqMan Assay for microRNAs
Cells were washed twice with PBS, and total RNA was isolated
using TRI-Reagent (Sigma, USA) according to manufacturer’s
instructions. For mRNA, cDNA was prepared by reverse
transcription-PCR (RT-PCR) using the high-capacity cDNA synthe-
sis kit (Applied Biosystems, USA) using the following program:
1 hour at 37C and 5 minutes at 95C. Quantitative RT-PCR (qRT-
PCR) was performed with KAPA SYBR FAST Universal kit (KAPA
Biosystems, USA) using the appropriate speciﬁc primers (listed in
Supporting Information Table S2) as follows: 3 minutes at 95C,
40 cycles of 5 seconds at 95C, 20 seconds at 60C, and 10 sec-
onds at 72C. For TaqMan assays of microRNAs (miRNAs), 5 μl
RNA (5 ng/μl) was subjected to RT-PCR using the reverse tran-
scription kit and miRNA-speciﬁc primers (Applied Biosystems,
USA) followed by qRT-PCR using TaqMan universal master mix
and TaqMan miRNA-probes or U54 as control (Applied Biosystems).
The relative amounts of each mRNA or miRNA were normalized to
glyceraldehyde-3-phosphate dehydrogenase or U54, respectively,
and the relative expression of each reaction was calculated as a
fold change relative to the control sample. Samples were cycled
using Applied Biosystems StepOnePlus RT-PCR system.
Tissue Processing and Staining
Tissues were obtained from three to ﬁve mice and prepared for
parafﬁn sections (5 μm). For immunoﬂuorescent staining, tissues
were dehydrated and then stained as detailed previously [2]
using rabbit anti-SOX2 1:400, mouse anti-P63 1:100 (Santa Cruz
Biotechnology, USA), goat anti-K12 1:400 (Santa Cruz Biotech-
nology, USA), rabbit anti-K15 1:500 (Abcam, UK; overnight at
4C). Next, samples were washed (0.2% tween 20, 0.2% gela-
tine), incubated with secondary antibody (Alexa Fluor 488 and
594 [Invitrogen, USA]), and mounted as above. In situ hybridiza-
tion for miR-450b was performed on whole embryos or on opti-
mal cutting temperature (OCT) compound frozen sections as
described previously [25].
Statistical Analysis
Data are presented as means  SD. Normality was ﬁrst evaluated
using Shapiro-Wilk test. Then, t test or analysis of variance
followed by Tukey’s test were performed, as indicated in
legends, to calculate p values. Differences were considered to be
statistically signiﬁcant from a p value below .05.
RESULTS
SOX2 Is Co-expressed with P63 by Stem/Progenitor
Cells of the Corneal Epithelium
To characterize the expression pattern of SOX2 in vivo, we per-
formed immunoﬂuorescent staining on parafﬁn sections of the
cornea of 2 months old mice. K15 and K12 antibodies were
used to label the limbus and cornea, respectively (Fig. 1A).
SOX2 was detected in the nucleus of stem/progenitor cells of
the limbus, in committed progenitors throughout the basal
layer of the corneal epithelium but not in supra basal differen-
tiated epithelial cells and no signal was found in the corneal
stroma (Fig. 1A, quantiﬁcation in Supporting Information
Fig. S1A, S1B). Interestingly, this expression pattern was very
similar and overlapping with the expression pattern of P63, a
well-known regulator of epithelial stem/progenitor cells. To fur-
ther investigate the relevance of these ﬁndings to human, we
established primary culture of human limbal epithelial stem/
progenitor cells. Limbal rings were obtained from donated
cadaveric cornea according to Helsinki ethical approval, the epi-
thelial layer was separated from the underlying stroma and epi-
thelial stem/progenitor cells were cultivated as detailed in
Materials and Methods section. To study the expression and
function of SOX2 during differentiation, limbal stem/progenitor
cells were grown in low (150 μM) calcium levels to minimize
spontaneous differentiation and then switched to high calcium
levels (1.2 mM) to induce cell differentiation and stratiﬁcation
for the indicated time. Cells were harvested prior to differentia-
tion induction (day 0) or following differentiation for 4–7 days.
RT-PCR and Western blot analyses conﬁrmed successful differ-
entiation accompanied by a decrease in the expression of
markers of stem/progenitor cells (P63 and K14) and an increase
in K12 that marks terminally differentiated cells (Fig. 1B, 1C).
Although SOX2 was detected in undifferentiated limbal epi-
thelial stem/progenitor cells (day 0), its levels were signiﬁ-
cantly reduced upon early differentiation at the mRNA and
protein levels (Fig. 1B, 1C). As compared to the expression in
limbal stem/progenitor cells, very low or no signal was found
in primary cultures of human limbal stromal cells or foreskin
epidermal cells. Yet, signiﬁcantly higher levels of SOX2
mRNA were documented in human pluripotent stem cells
(Fig. 1D). To further corroborate these data and explore the
cellular localization of SOX2 in human limbal epithelial stem/
progenitor cells, we performed immunostaining. As shown in
Figure 1E, 1F, SOX2 was detected in the nucleus of limbal
stem/progenitor cells, although some perinuclear and cyto-
plasmic signal was sometimes evident. Finally, SOX2 was co-
expressed with P63 (and K14) in undifferentiated cells,
whereas it was not expressed by K12-positive differentiated
cells (Fig. 1E, 1F). Altogether, these data indicate that SOX2 is
co-expressed with P63 by stem/progenitor cells of the corneal
epithelium.
SOX2 Regulates P63 Enhancer and P63 Expression
As SOX2 and P63 were co-expressed in stem/progenitor cells,
we hypothesized that they may coregulate each other. To this
end, we examined the possibility that SOX2 may regulate
putative promoter/enhancer regions of P63 and vice versa
using in silico analysis that predicts transcription factor binding
sites (MatInspector, GenomatixSuite v3.10). Conserved P63
www.StemCells.com ©2018 The Authors. STEM CELLS published by
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Figure 1. SOX2 is co-expressed with P63 in stem and progenitor cells of the corneal epithelium in vivo and in vitro. (A): Immunoﬂuores-
cence staining of the indicated proteins was performed on parafﬁn sections of the adult mouse cornea. The regions of the limbus, periph-
eral cornea, and corneal center are shown. (B, C, E, F): Primary human limbal epithelial cells were differentiated for the indicated times,
and the expression of the indicated marker was tested by quantitative real-time polymerase chain reaction (qPCR) (B) or Western blot
analysis (C) or immunostaining (E, F). ERK served as loading control in (C). (D): A comparative qPCR analysis of SOX2 in the following
human cells: primary FE, LS, LE, iPSC, and ESCs. (B, D): Data were normalized to housekeeping gene and is presented (mean  SD, n = 3)
as fold increase compared to control sample. Statistical analysis was performed by one-way analysis of variance followed by Tukey’s test
(*, p < .05; **, p < .01; ***, p < .001). (A, E, F): Nuclei were detected by DAPI counter staining. Scale bars are 25 μm (A) and 12 μm (E, F).
Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; ep, epithelium; ESC, embryonic stem cell; FE, foreskin epidermal cells; iPSC, induced
pluripotent stem cell; LE, limbal epithelium stem/progenitor cells; LS, limbal stromal cells; st, stroma.
©2018 The Authors. STEM CELLS published by
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consensus binding sites were not identiﬁed in SOX2 promoter/
enhancer regions. Interestingly, SOX2 consensus binding site
was identiﬁed in C38 (but not C40), an evolutionarily con-
served cis-regulatory enhancer [34]. The C38-C40 modules,
which reside in an intron of P63 gene, were shown to act in
synergism and were bound and controlled by P63 transcription
factor via multiple binding sites that facilitate self-regulatory
mechanism [34, 35] (Fig. 2A, 2B). To test the impact of SOX2
on P63 enhancer, HEK293 cells were co-transfected with SOX2
or P63 or empty plasmid (as control), together with luciferase
expression vector in which luciferase gene was cloned down-
stream to C38 or C40 enhancer sequences alone or in tandem
Figure 2. SOX2 can activate P63 enhancer and interact with P63 protein. (A, B): The sequence (A) and location (B) of C38 and C40
enhancers within P63 gene. Consensus binding sites of SOX2 and P63 are highlighted in pink and blue, respectively. (C): Schematic represen-
tation of luciferase construct containing C38, C40, C38-C40, and C38-C40-mutated constructs lacking the indicated P63 or SOX2 binding sites.
(D): HEK293 cells were co-transfected with the indicated luciferase construct and with SOX2 or P63 or control empty plasmid (−), as indi-
cated. Luciferase activity represents the relative read that was normalized to Renilla and presented as fold increase compared to control
sample (mean  SD, n = 3). Statistical signiﬁcance was assessed by one-way analysis of variance followed by Tukey’s test (*, p < .05;
**, p < .01; ***, p < .001). (E): HEK293 cells were co-transfected with plasmids encoding for SOX2 and myc-tagged P63. Lysates were col-
lected 2 days later and IP was performed with the indicated antibodies or with nonspeciﬁc antibodies (IgG) as control. Expression in lysates
is shown as control (input). Abbreviation: IP, immunoprecipitation.
www.StemCells.com ©2018 The Authors. STEM CELLS published by
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(C38-C40; as illustrated in Fig. 2C). Importantly, overexpression
of SOX2 signiﬁcantly enhanced the luciferase activity of C38
construct but had only mild and nonsigniﬁcant effect on C40,
which lacks SOX2 binding site (Fig. 2D). The effect of SOX2
on C38-C40 was even stronger compared to the induction of
C38, despite the fact that C40 alone was low or insensitive to
SOX2. This implies that the enhanced effect of SOX2 on
C38-C40 may involve cis-interaction between elements on C38
and C40. Next, we performed site-directed mutagenesis to dis-
rupt the binding site of SOX2. Indeed, the mutated construct
(C38-C40-MUT-SOX2) was insensitive to SOX2 transfection.
Altogether, this set of experiments strongly suggests that SOX2
activates P63 enhancer through the newly identiﬁed evolution-
ary conserved binding site.
To gain further insights on potential cis-interactions, we ﬁrst
tested the effect of P63 on these constructs. As expected from
a previous report [34], P63 transfection enhanced the activity of
C38 or C40 enhancers and caused an even stronger effect on
the combined construct (C38-C40), whereas the mutated con-
struct that lacks all P63 binding sites (C38-C40-P63-MUT) was
insensitive to P63 transfection (Fig. 2D). Interestingly, mutations
in P63 binding sites resulted in attenuated response to SOX2
effect. The latter observation together with the proximity of
SOX2 and P63 binding sites in C38 enhancer suggest that these
transcription factors may directly interact. To test this possibility,
we overexpressed SOX2 and P63 conjugated to a myc tag (myc-
P63) and performed co-immunoprecipitation assay. As shown in
Figure 2E, a signiﬁcant band of P63 was detected following
SOX2 pull-down, whereas SOX2 was detected following immu-
noprecipitation of myc-P63. P63 and SOX2 were detected in
lysates (input), whereas no signal was found following immuno-
precipitation using nonspeciﬁc IgG antibodies that were used as
negative control. Altogether, these data and the co-ocalization
of SOX2 and P63 suggest that SOX2 can regulate C38-C40
enhancers and may control the transcription of P63 mRNA.
SOX2 Is Essential to Maintain Stem/Progenitor Cell
State
To test whether SOX2 controls p63 gene in limbal stem/progeni-
tor cells, we performed knockdown experiments using esiRNA
against SOX2 (siSOX2) to induce speciﬁc and efﬁcient gene
silencing, and nonspeciﬁc sequences served as control (siCtl). As
shown in Figure 3A and 3B, siSOX2 signiﬁcantly inhibited SOX2
mRNA and protein. Importantly, SOX2 repression resulted in a
signiﬁcant reduction of P63 mRNA and protein, indicating that
SOX2 is upstream to P63. Moreover, SOX2 repression resulted in
a reduction in the expression of stem/progenitor markers
ABCG2 and K14 and an increase in differentiation markers K3
and K12 with no signiﬁcant impact on the expression of epider-
mal marker, K10 (Supporting Information Fig. S1C). Similarly,
transfection of esiRNA against P63 induced cell differentiation
(Supporting Information Fig. S1D, S1E, S1F), suggesting a com-
mon pathway for SOX2 and P63 in regulating stemness and dif-
ferentiation. To further assess the involvement of SOX2 in the
differentiation process, primary limbal stem/progenitor cells
were transfected and then subjected to calcium-induced differ-
entiation for 4 days. SOX2 inhibition resulted in reduced expres-
sion of ABCG2 and K14 (Fig. 3C) and a dramatic increase in
the differentiation markers (Fig. 3D). Moreover, siSOX2 reduced
the expression of K14 and induced the expression of K3 at the
protein level, as evident by Western blot (Fig. 3E) and ﬂow
cytometry (Fig. 3F) analyses. In line, SOX2 repression was corre-
lated with typical changes in cell morphology that occurred dur-
ing differentiation, for example, enlarged cell body, loss of
hexagonal organized pattern, and appearance of disorganized
colonies (Fig. 3G).
A well-known hallmark of LSCs is their ability to form long-
term proliferative large clones known as holoclones [14, 36].
P63 is known to be important for stemness and its repression
was shown to drastically affect colony-forming capacity of
LSCs. To further explore the role of SOX2 in regulating stem/
progenitor cells, undifferentiated limbal stem/progenitor cells
were transfected with siSOX2 or control esiRNA, seeded at clonal
density, and then allowed to expand for 2–3 weeks (as detailed
in Materials and Methods section). Notably, colony-forming efﬁ-
ciency was drastically affected by SOX2 depletion (Fig. 4A).
Quantiﬁcation revealed that the number of colonies signiﬁcantly
decreased (Fig. 4B) while the size of the remaining colonies was
profoundly smaller following SOX2 repression (Fig. 4C), suggest-
ing that SOX2 is essential for the long-term proliferative capacity
of LSCs. A comparable robust effect was also observed upon
P63 depletion (Fig. 4D, 4E, 4F), in line with a previous report
[14]. Finally, knockdown of SOX2 attenuated by ~25% the prev-
alence of Ki67+ proliferative cells (Fig. 4G, 4H) and led to ~40%
decrease in cell growth, as shown by the alamar blue viability
assay (Fig. 4I). Altogether, these data indicate that SOX2 is
required for cell proliferation while its inhibition enhances cell
differentiation.
Finally, we performed rescue experiment in which limbal
cells were co-transfected with siSOX2 with or without P63. While
siSOX2 reduced clonogenicity, forced expression of P63 restored
the colony formation (Fig. 5A, 5B; Supporting Information Fig. S2B)
with no signiﬁcant difference in cell death (Fig. 5C), and the expres-
sion of K14 and ABCG2 was signiﬁcantly restored (Fig. 5D). Given
that siRNA was efﬁciently delivered to the vast majority of the
cells (Supporting Information Fig. S2A) and that restored colonies
showed low SOX2 and high P63 (Supporting Information Fig. S2B),
these data suggest that P63 acts downstream to SOX2. Taken
together, these data suggest that SOX2 maintains stem/progenitor
cell state at least in part via the regulation of P63 expression.
The microRNA Cluster MIR450 Can Repress SOX2
Forced SOX2 knockdown in vitro had strong impact on cell
differentiation (Figs. 3, 4). The in vivo observation that SOX2 is
drastically downregulated upon the transition of cells from the
basal corneal epithelial layer to supra basal layers suggests that
an active and efﬁcient mechanism mediates SOX2 degradation
in supra basal differentiated cells. Such mechanism may be
mediated by miRNAs. Intriguingly, TargetScan algorithm (http://
www.targetscan.org/) predicted multiple potential binding sites
for members of MIR450 cluster (miR-450a and miR-450b) in
SOX2-30UTR (Fig. 6A, 6B). According to miRBase databases
(http://www.mirbase.org/index.shtml), MIR450 is a cluster of
miRNAs composed of six miRNA encoding genes (Fig. 6C).
Within this cluster, four miRNA genes (two copies of miR-450a
and single copies of miR-450b and miR-542) are at close prox-
imity to each other, while they are separated by 4,891 bases
from two additional miRNAs (miR-503, miR-424; illustrated in
Fig. 6C). This suggests that these two groups may be regulated
by separate promoter/enhancer elements. To test this possibil-
ity, we chose to examine the expression proﬁle of these miRNA
genes in the course of embryonic stem cell differentiation as
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large changes in gene expression during differentiation are
known to take place in this process. Human embryonic stem
cells were differentiated into corneal epithelial-like cells as pre-
viously reported [25, 27] and cells were collected at the indi-
cated time points for analysis. Indeed, each group displayed a
different expression proﬁle (Fig. 6D), suggesting that the two
groups of genes represent two separately regulated clusters.
Notably, miR-450a and miR-450b are well conserved in mam-
mals, and their seed sequence differs by a single nucleotide at
position 8, suggesting they may have both overlapping and sepa-
rate sets of target genes (Supporting Information Table S1). We
thus focused on miR-450b that had four predicted binding sites
on SOX2-30UTR. SOX2 is expressed in early eye development
[21, 22], in the adult cornea (Fig. 1), and in neural cells [37]. To
explore the expression of miR-450b in this context, we per-
formed whole mount in situ hybridization of mouse embryos at
different developmental stages. A low but signiﬁcant signal for
miR-450b was documented in the developing lens of 10-day-old
embryos (E10.5), and this signal dramatically peaked by E11.5
(Fig. 6E). Strikingly, this de novo expression coincided with a sig-
niﬁcant reduction in SOX2 protein shown by immunoﬂuorescent
staining of tissue sections (Fig. 6F). In the adult murine cornea,
miR-450b was low or not detected in the limbus but was speciﬁ-
cally expressed in the cornea of 2-month-old mice (Fig. 6G).
Closer inspection of the expression of miR-450b signal on tissue
sections has shown that miR-450b was low in corneal basal layer
(black arrow, Fig. 6H), whereas it was highly expressed by differ-
entiated supra basal layers (white arrow, Fig. 6H). Thus, miR-450b
Figure 3. SOX2 prevents cell differentiation. Primary limbal cells were transfected with siSOX2 or control esiRNA, and 72 hours later, the
expression of SOX2 and P63 was examined by real-time polymerase chain reaction (PCR) (A) or Western blot analysis (B). ERK served as load-
ing control. Quantitative real-time PCR analysis of the indicated markers of stem/progenitor cells (C) or markers of differentiated cells (D), or
cells were lysed and subjected to Western blot analysis of the indicated markers (E) (ERK served as loading control) or immunostaining of K3
was followed by ﬂow cytometry analysis (F). (G): The morphological changes upon siSOX2 repression are shown by bright ﬁeld microscopy
(×20 objective). (A, C, D): Data represent mean  SD, n = 3 and statistical signiﬁcance was assessed by t test (*, p < .05). Abbreviations:
esiRNA, endonuclease-digested silencing RNA; siSOX2, esiRNA against SOX2; siCtl, control esiRNA.
www.StemCells.com ©2018 The Authors. STEM CELLS published by
Wiley Periodicals, Inc. on behalf of AlphaMed Press 2018
Bhattacharya, Serror, Nir et al. 423
displays spatially inversed expression pattern with SOX2 in the
adult cornea (compare Fig. 6H with SOX2 pattern in Fig. 1A).
Similarly, a moderate inverse correlation between SOX2 and
miR-450b was found in the course of in vitro differentiation
and maturation of embryonic stem cells into speciﬁc neurons
(Supporting Information Fig. S3). These data suggest that miR-
450b may serve as a SOX2 repressor.
To test whether miR-450b can bind and repress SOX2
through interactions with SOX2-30UTR, we performed a lucifer-
ase assay in 293HEK cells. The 30UTR region of SOX2 which was
cloned downstream to a luciferase gene (SOX2-30UTR) and co-
transfected with synthetic oligonucleotide mimic of pre-miR-
450a (PM450a), pre-miR-450b (PM450b), or both, or scrambled
mimic that served as control (Ctl). Twenty-four hours later, cells
were lysed and luciferase activity was measured as detailed in
Materials and Methods section. As shown in Figure 7A, both
miRNAs inhibited luciferase activity when co-transfected with
SOX2-30UTR luciferase plasmid. However, a more signiﬁcant
decrease in the luciferase activity was observed in the presence
of miR-450b, in line with the fact that it contains four binding sites
in SOX2-30UTR. Additionally, enhanced repression was observed
when both miR-450a and miR-450b were co-transfected, suggest-
ing that they might act in synergism. To test whether this effect
depends on the binding to the predicted sites in SOX2-30UTR,
we performed site-directed mutagenesis. All ﬁve binding sites
for miR-450a and miR-450b were disrupted by point mutations
in a mutated construct (MUT-SOX2-30UTR) that was generated
(Supporting Information Fig. S4). Evidently, the luciferase activity
of the mutated construct was insensitive to miR-450b, suggesting
that miR-450b binds to these predicted sites to repress SOX2
(Fig. 7A).
To further test this possibility and its relevance to human,
we tested the expression of SOX2 and miR-450b during differen-
tiation of human limbal stem/progenitor cells. As shown in
Figure 4. SOX2 regulates long-term colony-forming efﬁciency and cell proliferation. Limbal cells were transfected with siSOX2 or siP63 or
siCtl and 48 hours later, subjected to clonogenicity test as detailed in Materials and Methods section. Colonies were visualized by Rhodamin
staining 3 weeks later (A, D), and quantiﬁcation of the number of colonies relative to control (B, E) and the average size of colonies (C, F)
was performed by Nis-Element software as detailed in Materials and Methods section. (G–I): Limbal stem/progenitor cells were transfected
with siSOX2 or siCtl and 72 hours later, cells were immunostained for the proliferative marker Ki67 (G), and quantiﬁcation (by Nis-Element
software) of the relative number of Ki67-positive cells is shown (H). Transfectents were grown for 72 hours and then subjected to alamar
blue viability test (I). (B, C, E, F, H, I): Data represent mean  SD, n = 3. Signiﬁcance assessed by t test (*, p < .05). Nuclei were counter-
stained with DAPI and scale bars are 30 μm. Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; siSOX2, endonuclease-digested silencing
RNA against SOX2; siP63, endonuclease-digested silencing RNA against P63; siCtl, control endonuclease-digested silencing RNA.
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Figure 7B, as SOX2 decreased during differentiation, the levels
of miR-450a and miR-450b signiﬁcantly increased. As miR-450b
had multiple binding sites (Fig. 6A, 6B) and showed enhanced
repression (Fig. 7A), we transfected human limbal stem/progeni-
tor cells with miR-450b mimic (PM) or control pre-miR sequence
(Ctl), and transfection efﬁciency was validated by RT-PCR analy-
sis (Supporting Information Fig. S5). A signiﬁcant repression of
SOX2 and P63 (Fig. 7C) further supported the hypothesis that
miR-450b is a direct repressor of SOX2. Similar to the effect of
siSOX2, transfection with PM resulted in a decrease in the
stem/progenitor marker K14, cell proliferation (Fig. 7C, 7D),
reduced clonogenic potential (Fig. 7E, 7F), and an increase in
the differentiation marker K3 (Fig. 7C). Finally, miR-450b antago-
nist had an opposite effect on cell differentiation (Fig. 7G), pro-
liferation (Fig. 7H), and clonogenic capacity (Fig. 7I, 7J). Taken
together, we conclude that SOX2 regulates P63 and maintains
the stem/progenitor cell state, whereas miR-450b represses
SOX2 and induces cell differentiation at least in part, by directly
targeting SOX2 and consequently by affecting P63 pathway.
DISCUSSION
It is likely that some of SOX2 functions are common in different
cellular contexts, including regulation of stem cell self-renewal,
asymmetric cell division, and chromatin remodeling. In neurons,
it was proposed that SOX2 regulates stemness [37] and cooper-
ates with other proteins to prevent the activity of polycomb
repressive complex 2 [38, 39]. In this study, we show that SOX2
is expressed by stem/progenitor cells of the corneal epithelium
and support their state. We propose that at least partly, SOX2
mediates its functions through the control of P63 expression.
A newly identiﬁed SOX2 consensus binding site was found in
C38, a putative enhancer of P63 gene [34]. We therefore pro-
pose that through the binding to this speciﬁc site, SOX2 regu-
lates the expression of P63. Additionally, few observations from
this study support the hypothesis that SOX2 and P63 cooperate
through physical interaction: (i) the close proximity of P63 and
SOX2 binding sites on C38, (ii) disruption of P63 sites by muta-
genesis also affected SOX2-mediated enhancer activation, and
Figure 5. P63 rescues stemness in SOX2 knockdown cells. Limbal cells were co-transfected with siSOX2 or siCtl and P63 expression plas-
mid or empty plasmid (veh). Seventy-two hours later, cells were subjected to clonogenicity test (A), and number of the colonies were
quantiﬁed by Nis-Element software as detailed in Materials and Methods section (B). (C): Cells were taken for trypan blue assay to quan-
tify dead cells after transfection of indicated factors. Quantitative real-time polymerase chain reaction analysis of the indicated markers
of stem/progenitor cells were performed (D). (B–D): Data represents mean  SD, n = 3. Statistical signiﬁcance was assessed by one-way
analysis of varaince followed by Tukey0s test (*, p < .05; **, p < .01; ***, p < .001). Abbreviations: siSOX2, endonuclease-digested silencing
RNA against SOX2; siCtl, control endonuclease-digested silencing RNA.
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Figure 6. Evidence for MIR450 cluster as a potential repressor of SOX2. (A): Schematic representation of the 30UTR of human SOX2 and
predicted binding site of miR-450a and miR-450b identiﬁed by TargetScan. (B): Sequence and complementation of the predicted binding
site. (C): Illustration of the human MIR450 cluster (deﬁned by miRBase) that includes six miRNAs genes. (D): Human embryonic stem cells
were seeded on collagen IV-coated dishes in the present of corneal ﬁbroblast conditional media to induce corneal epithelial differentia-
tion for the indicated time. Relative expression of the indicated miRNAs is shown and data represent the normalized expression as fold
change in expression relative to undifferentiated cells. (E): Wholemount in situ hybridization for miR-450b on mouse embryos of the indi-
cated embryonic day. Increased magniﬁcations are shown from left to right, and lens is annotated by white arrowheads. (F): Immunoﬂuo-
rescence staining of SOX2 on mouse head sections at E10.5 and E11.5. Nuclei were counterstained with DAPI. (G, H): In situ hybridization
of miR-450b on whole cornea (G) or sections of cornea (H) of 2-month-old mice. Scale bars are 250 μm (E, G) and 25 μm (F, H). Abbrevia-
tions: DAPI, 40,6-diamidino-2-phenylindole; lp, lens pit; lv, lens vesicle; oc, optic cup; pce, presumptive corneal epithelium; UTR, untrans-
lated region.
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Figure 7. miR-450b represses SOX2 and induces differentiation of limbal epithelial stem/progenitor cells. (A): 293HEK cells were
co-transfected with SOX2-30UTR luciferase plasmid or with a mutated plasmid with disrupted miR-450a, b binding sites (Mut-
SOX2-30UTR, see Fig. S4), and with pre-miR-450a (PM450a) or pre-miR-450b-5p (PM450b) or both or control (CtlPM), as indicated.
Data represent the normalized luciferase activity relative to control sample. (B): Primary human limbal stem/progenitor cells were
induced to differentiate for the indicated time and the expression of the indicated genes was examined by quantitative polymerase
chain reaction. (C–J): Primary human limbal stem/progenitor cells were transfected with PM or AM or Ctl and then subjected to dif-
ferentiation for 4 days and Western blot analysis of the indicated genes (C, G), or transfectants were allowed to grow for 72 hours
and then cell viability was tested by alamar blue assay (D, H), or transfectants were subjected to clonogenicity test and
colonies were revealed by rhodamine staining (E, I) and quantiﬁed (F, J) by Nis-Element software. Data represent mean  SD, n = 3.
(A, B): Statistical signiﬁcance was assessed by one-way analysis of variance followed by Tukey’s test and (D, F, H, J) t test (*, p < .05;
**, p < .01; ***, p < .001). Abbreviations: AM, pre-miR-450b mimic antagonist; Ctl, control pre-miR sequence; PM, pre-miR-450b
mimic
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(iii) these two proteins could co-immunoprecipitate and display
overlapping functions. Altogether, it is tempting to hypothesize
that SOX2 and P63 interact in vivo at least in the context of
C38-C40-mediated activation of P63 transcription and potentially
in additional genomic loci to control the regulation of stem/
progenitor cell state and prevent cell differentiation. In line with
this model, a recent study reported the co-occupancy of SOX2
and P63 in genomic loci and their cooperation in the regulation
of gene expression in squamous cell carcinoma [40, 41].
Like other members of the SOX family, SOX2 possesses low
DNA-binding afﬁnity [42]. Therefore, SOX2 interactions with
cofactors are essential to propagate its function. It would be
therefore interesting to characterize SOX2 genomic binding
sites and explore its interactions with potential coregulatory
factors such as P63 and PAX6. Such cooperation is expected to
control the corneal epithelial differentiation program, corneal
avascularity, and/or corneal cell identity. In contrast to P63
that seemingly plays an overlapping role in the cornea and epi-
dermis [13–15, 43], SOX2 was not detected in epidermal cells
[44] (Fig. 1D). This expression pattern seems to be similar to
that of PAX6 that could induce transdifferentiation of epider-
mal cells into corneal epithelial-like cells [45–47]. In fact, SOX2
and PAX6 have already been shown to coordinate key event in
early lens placode development [21]. Altogether, it is possible
that some of SOX2-mediated functions reported here are
driven by SOX2 interactions with P63 and/or PAX6.
Our experiments suggest that SOX2 plays a role as a guard-
ian of stem/progenitor cell state. Knockdown of SOX2 dramati-
cally reduced the clonogenic potential of primary limbal stem/
progenitor cells, induced a reduction in stem/progenitor cell
markers, and attenuated cell proliferation. Notably, SOX2 was
found to be expressed not only by stem/progenitor cells located
in the limbus but also by corneal committed progenitor cells
(i.e., basal corneal epithelial cells). In fact, it is likely that SOX2
prevents the terminal differentiation of corneal committed pro-
genitors. SOX2 was detected in basal corneal progenitor cells
but absent from terminally differentiated cells in vivo, while
SOX2 inhibition by siRNA or by miR-450b induced signiﬁcant cell
differentiation in vitro. Thus, these data strongly suggest that
SOX2 is essential for preventing terminal differentiation.
The rapid loss of SOX2 signal upon detachment from the
basal cell layer implies for active mechanisms to remove
residual SOX2. We propose that this mechanism is mediated by
miR-450b, which is a direct repressor of SOX2 that induces cell
differentiation. The 30UTR of SOX2 contains multiple binding
sites for miR-450b. In line, miR-450b reduced SOX2, P63, clono-
genicity, and cell proliferation and induced cell differentiation.
These results of miR-450b transfection were similar to the
effects of SOX2 siRNA, suggesting that by directly repressing
SOX2, miR-450b induces differentiation of corneal epithelial
cells. Yet, like other miRNAs, miR-450b may have multiple
target genes other than SOX2. In fact, PAX6 is a targeted by
miR-450b and this regulation was shown to be important for
corneal epithelial lineage commitment of embryonic stem cells
[25]. Collectively, given that miR-450b targets these key tran-
scription factors, it seems that miR-450b may be an important
miRNA that rewards further investigation in vivo and in pathol-
ogy. SOX2 and PAX6 share common roles in eye development
and in the maintenance of neural SC self-renewal. However,
very little is known regarding the regulation of their expression.
The remarkable number of ﬁve binding sites in SOX2 30UTR, the
efﬁcient repression in vitro, and the clear reciprocal expression
in lens development in vivo suggest that miR-450b is a key
regulator of SOX2. Knockout of SOX2 in human and mice led to
an early failure in eye development and anophthalmia, whereas
point mutation in one allele of SOX2 is linked with mental retar-
dation and multiple eye defects [17–20]. Therefore, incorrect
dosage of SOX2 because of miR-450b deﬁciency or its hyper
activation is expected to result in eye and neural abnormalities.
Thus, it would be interesting to examine the regulation of SOX2
by miR-450b in vivo and its potential association with corneal
and/or neural hereditary diseases.
CONCLUSION
Altogether, we propose that SOX2 controls P63 and that both
transcription factors are essential regulators of stem cell pro-
genitor cell states in the corneal epithelium. In line with this
model, mutations in these genes were linked with congenital
eye pathologies that involve corneal abnormalities. It will be of
importance to further characterize the interactions between
SOX2 and P63, and their signaling network in different cellular
compartments in the corneal epithelium in health and disease.
A better understanding of the molecular network that is con-
trolled by these key transcription factors will shed light on LSC
self-renewal pathways and will potentially be harnessed into
novel therapeutic approaches for corneal pathologies.
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